BCL11B-rearrangement, BCL11B expression, T-ALL, MPAL T/M phenotype, optical genome mapping, partner genes
Chronic myeloid leukemia, complete cytogenetic response, chronic phase, blasts phase, tyrosine kinase inhibitor, ABL1 mutation, additional chromosomal abnormality